89Zr-Bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic neurofibromatosis type 2. 89Zr-BevacizumabPET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment ...
89Zr-Bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic neurofibromatosis type 2. - 89Zr-Bevacizumab PET/CT imaging in NF2 patients 89Zr-BevacizumabPET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment ...
Neurofibromatosis type 2;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Product Name: 89Zr-bevacizumab INN or Proposed INN: Unknown Other descriptive name: BEVACIZUMAB ZIRCONIUM ZR-89 Product Name: 89Zr-bevacizumab INN or Proposed INN: Unknown Other descriptive name: BEVACIZUMAB ZIRCON ...